Clinical Trial Update: Trial of STAHIST in Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 trial of STAHIST for seasonal allergic rhinitis has completed, according to ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• STAHIST

Snippet

Sponsor: Magna Pharmaceuticals, Inc. | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED